PROKIDNEY CORP.

Analyst Reco. ProKidney Corp.

Equities

PROK

KYG7S53R1049

End-of-day quote Nasdaq Other stock markets 06:00:00 2024-05-21 pm EDT			5-day change	1st Jan Change
3.62 ^USD	-2.16%		-7.65%	+103.37%

May. 10	ProKidney Q1 Loss Unchanged From Year Earlier	MT
May. 10	ProKidney Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

BofA Securities Downgrades ProKidney to Neutral From Buy, Cuts Price Target to $2 From $8	Jan. 02	MT
BTIG Initiates ProKidney With Buy Rating, $16 Price Target	23-07-25	MT
Jefferies Initiates ProKidney With Buy Rating, Price Target is $15	22-12-21	MT
Morgan Stanley Starts ProKidney at Equalweight With $13 Price Target	22-11-10	MT
UBS Initiates Coverage on ProKidney With Buy Rating, $18 Price Target	22-10-18	MT
Citigroup Starts ProKidney at Buy With $16 Price Target	22-10-14	MT
BofA Securities Starts ProKidney at Buy With $14 Price Target	22-09-23	MT
Evercore ISI Initiates Coverage on ProKidney With Outperform Rating	22-09-02	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer